CELL INTELLIGENCE · 肿瘤细胞治疗研究

胶质瘤中的 NK 细胞功能障碍：从免疫逃逸到免疫治疗

Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy.

胶质母细胞瘤的 CAR-T 细胞治疗：克服当前障碍与提升疗效的策略及其治疗意义

Chimeric antigen receptor T cell therapy for glioblastoma: overcoming current barriers and strategies to enhance efficacy for therapeutic implications

溶瘤病毒 OVV-03 通过免疫调节与特异性 HER2 上调增强针对胶质母细胞瘤的 CAR-T 细胞治疗

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation.

CAR-T 疗法治疗中枢神经系统肿瘤的进展

Advances in CAR-T therapy for central nervous system tumors.

抗胶质瘤 CAR-T 细胞免疫治疗靶点的表达特征

Expression features of targets for anti-glioma CAR-T cell immunotherapy.

抗胶质瘤 CAR-T 靶点在不同胶质瘤亚型中表达异质、肿瘤覆盖情况不同，并与胶质瘤的恶性或免疫表型密切相关。

靶向 HER2 的 CAR-T 细胞在体外和体内均对胶质母细胞瘤表现出高效抗肿瘤活性

HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo.

CAR-T 细胞治疗胶质母细胞瘤的现状与进展

Present Status and Advances in Chimeric Antigen Receptor T Cell Therapy for Glioblastoma.

对流增强递送局部产生 ErbB2/Her2 特异性 CAR-巨噬细胞的纳米封装基因用于脑干胶质瘤免疫治疗

Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2/Her2-specific CAR-macrophages for brainstem glioma immunotherapy.

CAR-T 细胞：治疗脑肿瘤及其他疾病的工程化免疫细胞

CAR T cells: engineered immune cells to treat brain cancers and beyond.

2009 至 2021 年 CAR-T 细胞的文献计量学与知识图谱分析

A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021.

作为一种具有巨大潜力和临床应用前景的抗肿瘤疗法，CAR-T 细胞疗法仍处于快速发展阶段。CAR-T 细胞相关领域在未来仍将是研究热点。